NTRB vs. LFWD, RBOT, MLSS, LPCN, COCH, CLGN, BGXX, CYTH, UNCY, and XAIR
Should you be buying Nutriband stock or one of its competitors? The main competitors of Nutriband include ReWalk Robotics (LFWD), Vicarious Surgical (RBOT), Milestone Scientific (MLSS), Lipocine (LPCN), Envoy Medical (COCH), CollPlant Biotechnologies (CLGN), Bright Green (BGXX), Cyclo Therapeutics (CYTH), Unicycive Therapeutics (UNCY), and Beyond Air (XAIR). These companies are all part of the "medical" sector.
ReWalk Robotics (NASDAQ:LFWD) and Nutriband (NASDAQ:NTRB) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their valuation, risk, earnings, dividends, media sentiment, analyst recommendations, institutional ownership, profitability and community ranking.
ReWalk Robotics and Nutriband both received 3 outperform votes by MarketBeat users. However, 100.00% of users gave ReWalk Robotics an outperform vote while only 37.50% of users gave Nutriband an outperform vote.
In the previous week, ReWalk Robotics had 5 more articles in the media than Nutriband. MarketBeat recorded 8 mentions for ReWalk Robotics and 3 mentions for Nutriband. ReWalk Robotics' average media sentiment score of 1.09 beat Nutriband's score of 0.70 indicating that Nutriband is being referred to more favorably in the news media.
ReWalk Robotics has a net margin of -134.52% compared to ReWalk Robotics' net margin of -262.94%. Nutriband's return on equity of -35.41% beat ReWalk Robotics' return on equity.
26.8% of ReWalk Robotics shares are held by institutional investors. Comparatively, 19.7% of Nutriband shares are held by institutional investors. 2.1% of ReWalk Robotics shares are held by insiders. Comparatively, 43.2% of Nutriband shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.
Nutriband has lower revenue, but higher earnings than ReWalk Robotics. Nutriband is trading at a lower price-to-earnings ratio than ReWalk Robotics, indicating that it is currently the more affordable of the two stocks.
ReWalk Robotics has a beta of 2.06, suggesting that its stock price is 106% more volatile than the S&P 500. Comparatively, Nutriband has a beta of 0.97, suggesting that its stock price is 3% less volatile than the S&P 500.
ReWalk Robotics currently has a consensus price target of $13.00, suggesting a potential upside of 175.42%. Given Nutriband's higher probable upside, research analysts plainly believe ReWalk Robotics is more favorable than Nutriband.
Summary
ReWalk Robotics beats Nutriband on 11 of the 16 factors compared between the two stocks.
Get Nutriband News Delivered to You Automatically
Sign up to receive the latest news and ratings for NTRB and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding NTRB and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Nutriband Competitors List
Related Companies and Tools
